Latest News in the pharma Industry

Research & Development

FDA Approves Gazyva sBLA with New Data in Previously Untreated Chronic Lymphocytic Leukemia

FDA Approves Gazyva sBLA with New Data in Previously Untreated Chronic Lymphocytic Leukemia

29 Dec 2014

Read more 
Cytokinetics and Astellas Expand Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications

Cytokinetics and Astellas Expand Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications

24 Dec 2014

Read more 
Lilly Announces Diabetes Research Partnership with University of Surrey

Lilly Announces Diabetes Research Partnership with University of Surrey

23 Dec 2014

Read more 
ADDC and AstraZeneca Collaborate to Support Five High Throughput Screening Proposals for New Therapeutic Targets

ADDC and AstraZeneca Collaborate to Support Five High Throughput Screening Proposals for New Therapeutic Targets

23 Dec 2014

Read more 
Roche Discontinues Phase III Trial of Gantenerumab

Roche Discontinues Phase III Trial of Gantenerumab

22 Dec 2014

Read more 
Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology

Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology

19 Dec 2014

Read more 
Enamine Extends Collaboration with Sanofi in Early Drug Discovery

Enamine Extends Collaboration with Sanofi in Early Drug Discovery

18 Dec 2014

Read more 
First Patients Enrolled in Epigenomics’ Epi proColon ADMIT Study

First Patients Enrolled in Epigenomics’ Epi proColon ADMIT Study

18 Dec 2014

Read more 
Top 30 Pharma Companies Spent $112 Billion on R&D in 2013

Top 30 Pharma Companies Spent $112 Billion on R&D in 2013

17 Dec 2014

Read more 
Targeting Pharmacoresistant Epilepsy and Epileptogenesis with Eslicarbazepine Acetate

Targeting Pharmacoresistant Epilepsy and Epileptogenesis with Eslicarbazepine Acetate

17 Dec 2014

Read more 
Proteins Drive Cancer Cells to Change States

Proteins Drive Cancer Cells to Change States

16 Dec 2014

Read more 
Genentech Submits NDA to FDA for Investigational Cobimetinib Used in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma

Genentech Submits NDA to FDA for Investigational Cobimetinib Used in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma

15 Dec 2014

Read more